In the Dutch AML cohort, 44 of 461 cases (10%) expressed IRX5 at high level (i.e., probeset [210239_at] value of log2 > 7.1), and in every case there was also high IRX3 expression (data not shown). This evidence concerns the gene IRX5 and acute myeloid leukemia.